$RGBP The Growing Demand for Cancer Treatment is Raising Immunotherapy Regen's screening process demonstrated that its recently identified novel chemical compounds appear to inhibit NR2F6 and show potential for treating #autoimmune #diseases such as #Lupus.
https://www.prnewswire.com/news-releases/rege...09898.html